Answers are grounded in this paper and cite their sources.
Dear Editor, The healthcare system in India faces a critical issue regarding the misrepresentation and underutilization of clinical pharmacologists, which compromises both professional integrity and patient safety. This problem stems from a long-standing practice where private hospitals and industries hire pharmacists in the guise of clinical pharmacologists. While this was previously justified by the limited availability of medical doctors with specialized training in clinical pharmacology, the scenario has significantly evolved. With an increasing number of medical doctors graduating every year with MD in Pharmacology and DM in Clinical Pharmacology degrees, the justification for hiring pharmacists for roles requiring clinical expertise is no longer valid. Clinical pharmacologists undergo an intensive educational and training journey that includes MBBS (5.5 years), MD Pharmacology (3 years), and DM Clinical Pharmacology (3 years). This equips them with unique competencies in therapeutic decision-making, patient care, and the application of pharmacological principles in clinical settings.[1-4] In contrast, pharmacists – qualified through BPharm, MPharm, or PharmD programs – bring valuable expertise in drug formulation, dispensing, and pharmaceutical research but lack the clinical training required for direct patient care and therapeutic decision-making. Despite these clear distinctions, private hospitals and industries continue to prioritize economic considerations over professional qualifications, thereby compromising healthcare quality. This issue extends to academic and research institutions as well. In government and private medical colleges, only medical doctors with MBBS and MD degrees are eligible to teach clinical pharmacology. However, in central institutions, nonmedical professionals with PhDs in pharmacology are also permitted to teach medical students. While nonmedical PhD holders contribute significantly to preclinical research, they may not possess the clinical insight required to effectively teach patient-care perspectives, which is critical for medical education.[4] A particularly concerning issue is the position of the Drug Controller General of India (DCGI), who plays a pivotal role in regulating drug approvals, clinical trials, and pharmacovigilance in the country. Ideally, this post should be held by a clinical pharmacologist, given their in-depth knowledge of drugs, clinical trial protocols, and patient safety measures. However, the position has historically been occupied exclusively by pharmacists, largely because the eligibility criteria are framed in a way that excludes clinical pharmacologists from applying. This exclusion undermines the potential for a more scientifically sound and patient-oriented regulatory framework, which is crucial for ensuring the efficacy and safety of drugs approved in India.[5] In the pharmaceutical industry and clinical research organizations (CROs), the underutilization of clinical pharmacologists remains a significant concern. While nonmedical professionals often contribute expertise in regulatory compliance, drug development, and pharmacovigilance, these roles frequently lack the essential patient-centric focus that clinical pharmacologists provide. Clinical pharmacologists play a pivotal role in enhancing patient safety and individualized care through initiatives such as Clinical Pharmacological Reconciliation, Review, and Feedback.[6,7] Clinical pharmacologists enhance medication safety and therapeutic efficacy by systematically evaluating prescriptions for appropriateness, identifying potential drug interactions, and tailoring treatments based on individual patient needs and resource constraints. Their contributions extend to optimizing polypharmacy management, mitigating adverse drug reactions, and promoting the rational use of medicines through evidence-based recommendations. By collaborating with healthcare teams and providing critical feedback, clinical pharmacologists play an indispensable role in elevating healthcare standards and integrating strategic medication management within a patient-centered framework. A recent survey conducted in private hospitals in Kolkata underscores the discrepancies in the qualifications of individuals employed in clinical pharmacologist roles. Findings reveal that nonmedical professionals often fill these positions despite lacking essential clinical training.[8] This ground reality calls for a re-evaluation of qualification criteria to align with global best practices and ensure competency in these critical roles. Given these challenges, a multipronged approach is necessary: Regulatory reforms: The roles of clinical pharmacologists and pharmacists must be clearly defined by regulatory bodies such as the National Medical Commission and the Pharmacy Council of India. Mandatory qualification verification should be enforced for specific job roles DCGI position eligibility: The eligibility criteria for the post of DCGI must be revised to allow clinical pharmacologists to apply. Their expertise would bring a critical, patient-focused perspective to the drug regulatory framework Utilization of trained professionals: With the growing number of medical doctors specializing in pharmacology, healthcare institutions must prioritize hiring appropriately qualified clinical pharmacologists for roles requiring patient-care expertise Educational standards: Academic institutions, especially central ones, must reconsider allowing nonmedical professionals to teach pharmacology to medical students. Patient-care education requires instructors with firsthand clinical experience[2,3] Industry practices: Corporate sectors and CROs should integrate clinical pharmacologists into roles that demand expertise in therapeutic decision-making, clinical trial design, and patient safety Public awareness: Educating healthcare administrators and policymakers about the distinct competencies of clinical pharmacologists and pharmacists will help eliminate misrepresentation and foster better utilization of each profession Stronger penalties: Institutions that misrepresent professional roles should face stringent penalties, as such practices jeopardize patient safety and undermine the integrity of the healthcare system. This issue represents an opportunity for India to redefine professional standards in healthcare and establish a robust system that values specialized expertise. The increased availability of medical doctors trained in pharmacology should be leveraged to enhance the quality of healthcare delivery and restore trust in the profession. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: